BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3653773)

  • 61. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
    Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
    J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Failure of second-look laparotomy to influence survival in epithelial ovarian cancer.
    Luesley D; Lawton F; Blackledge G; Hilton C; Kelly K; Rollason T; Wade-Evans T; Jordan J; Fielding J; Latief T
    Lancet; 1988 Sep; 2(8611):599-603. PubMed ID: 2900980
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Second-look laparotomy.
    Moore JL; Barter JF
    Semin Surg Oncol; 1994; 10(4):276-82. PubMed ID: 8091069
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Second-look laparotomy in the management of epithelial ovarian carcinoma: an evaluation of fifty cases.
    Luesley DM; Chan KK; Fielding JW; Hurlow R; Blackledge GR; Jordon JA
    Obstet Gynecol; 1984 Sep; 64(3):421-6. PubMed ID: 6462573
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Second-look laparotomy in ovarian carcinoma patients after 8 and after 12 courses of cisplatin-based chemotherapy.
    Menczer J; Ben-Baruch G; Modan M; Brenner H
    Gynecol Obstet Invest; 1989; 27(2):102-4. PubMed ID: 2731767
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Second look laparotomy in the management of epithelial cell carcinoma of the ovary.
    Mead GM; Williams CJ; MacBeth FR; Boyd IE; Whitehouse JM
    Br J Cancer; 1984 Aug; 50(2):185-91. PubMed ID: 6466536
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of second-look laparotomy in the management of patients with stage II, III and IV ovarian cancers following chemotherapy with cisplatin, adriamycin and cyclophosphamide.
    Kirwan PH; Naftalin NJ; Khanna S; Aukett RJ
    Br J Obstet Gynaecol; 1986 Jun; 93(6):629-33. PubMed ID: 3730331
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
    Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary.
    Peters WA; Smith MR; Cain JM; Lee RB; Yon JL
    Gynecol Oncol; 1992 Nov; 47(2):146-9. PubMed ID: 1468691
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Optimal debulking following chemotherapy of advanced-stage epithelial ovarian carcinoma.
    Piura B; Glezerman M
    J Surg Oncol; 1989 Apr; 40(4):237-40. PubMed ID: 2927136
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer].
    Meier W; Römisch M; Hepp H
    Geburtshilfe Frauenheilkd; 1993 Dec; 53(12):860-5. PubMed ID: 8119569
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Second-look laparotomy for ovarian carcinoma.
    Copeland LJ
    Clin Obstet Gynecol; 1985 Dec; 28(4):816-23. PubMed ID: 4075633
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Second-look laparotomy in carcinoma of the fallopian tube.
    Barakat RR; Rubin SC; Saigo PE; Lewis JL; Jones WB; Curtin JP
    Obstet Gynecol; 1993 Nov; 82(5):748-51. PubMed ID: 8414320
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The second-look celiotomy in ovarian cancer.
    Rocereto TF; Mangan CE; Giuntoli RL; Sedlacek TV; Ball HJ; Mikuta JJ
    Gynecol Oncol; 1984 Sep; 19(1):34-45. PubMed ID: 6469089
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Peritoneal washing cytology at second-look laparotomy in cisplatin-treated ovarian cancer patients.
    Kudo R; Takashina T; Ito E; Mizuuchi H; Sagae S; Moriwaka O; Tamagawa A
    Acta Cytol; 1990; 34(4):545-8. PubMed ID: 2375223
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Second-look surgery (SLO) in the management of carcinoma of the ovary.
    Hernádi Z; Sápy T; Lukácskó L; Borsos A
    Acta Chir Hung; 1997; 36(1-4):128-9. PubMed ID: 9408314
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.
    Rose PG; Faulhaber P; Miraldi F; Abdul-Karim FW
    Gynecol Oncol; 2001 Jul; 82(1):17-21. PubMed ID: 11426956
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report.
    Method MW; Serafini AN; Averette HE; Rodriguez M; Penalver MA; Sevin BU
    Cancer; 1996 Jun; 77(11):2286-93. PubMed ID: 8635097
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission.
    Dufour P; Bergerat JP; Barats JC; Giron C; Duclos B; Dellenbach P; Ritter J; Renaud R; Audhuy B; Oberling F
    Cancer; 1994 Apr; 73(7):1865-9. PubMed ID: 8137212
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma].
    Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
    Zentralbl Gynakol; 1988; 110(22):1443-8. PubMed ID: 3223119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.